These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10417540)

  • 1. Porokeratosis in patients with hepatitis C virus infection: does hepatitis C virus infection provide a link between porokeratosis and immunosuppression?
    Mizukawa Y; Shiohara T
    Br J Dermatol; 1999 Jul; 141(1):163-4. PubMed ID: 10417540
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperkeratotic variant of porokeratosis in a patient with Hepatitis C virus infection and a concomitant immunosuppressed state.
    Parekh V; Kabihting FD; Junkins-Hopkins JM
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eruptive disseminated superficial porokeratosis associated with acute hepatitis E].
    Dumas M; Corre F; Payancé A; Guedj N; Durand F; Descamps V; Le Bozec P
    Ann Dermatol Venereol; 2019 Oct; 146(10):655-658. PubMed ID: 31326131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porokeratosis in immunosuppressed and nonimmunosuppressed patients.
    Raychaudhuri SP; Smoller BR
    Int J Dermatol; 1992 Nov; 31(11):781-2. PubMed ID: 1428428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of porokeratosis of Mibelli in organ transplant recipients: lack of a search for transmissible agents in these patients.
    Mizukawa Y; Shiohara T
    J Am Acad Dermatol; 2001 Jan; 44(1):143-4. PubMed ID: 11148495
    [No Abstract]   [Full Text] [Related]  

  • 6. Porokeratosis and immunosuppression.
    Bencini PL; Tarantino A; Grimalt R; Ponticelli C; Caputo R
    Br J Dermatol; 1995 Jan; 132(1):74-8. PubMed ID: 7756155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Squamous cell carcinoma and disseminated superficial actinic porokeratosis].
    Rémond B; Dompmartin A; Mandard JC; Leroy D
    Ann Dermatol Venereol; 1994; 121(1):50-2. PubMed ID: 8092731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation.
    Torres J; Aguado JM; San Juan R; Andrés A; Sierra P; López-Medrano F; Morales JM
    Transpl Int; 2008 Sep; 21(9):873-8. PubMed ID: 18482173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of porokeratosis in renal transplant recipients.
    Herranz P; Pizarro A; De Lucas R; Robayna MG; Rubio FA; Sanz A; Contreras F; Casado M
    Br J Dermatol; 1997 Feb; 136(2):176-9. PubMed ID: 9068727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are porokeratoses an infection?
    Webster GF
    Arch Dermatol; 2001 May; 137(5):665. PubMed ID: 11346352
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal acute hepatitis C virus infection in patients with hematological malignancies.
    Taliani G; Tozzi A; Fanci R; Biliotti E; Bosi A
    J Chemother; 2006 Dec; 18(6):662-4. PubMed ID: 17267347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porokeratosis of Mibelli induced by topical corticosteroid.
    Yazkan F; Turk BG; Dereli T; Kazandi AC
    J Cutan Pathol; 2006 Jul; 33(7):516-8. PubMed ID: 16872477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Punctate porokeratosis in a renal transplant recipient.
    Touraud JP; Dalac S; Collet E; Tanter Y; Justrabo E; Dutronc Y; Lambert D
    Clin Exp Dermatol; 2003 May; 28(3):329-30. PubMed ID: 12780730
    [No Abstract]   [Full Text] [Related]  

  • 16. Porokeratosis in a patient with hepatitis of unclear etiology.
    Mundi JP; Cerullo L; Cotliar J
    J Drugs Dermatol; 2010 Mar; 9(3):258-60. PubMed ID: 20232588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eruptive disseminated porokeratosis: a new classification system.
    Shoimer I; Robertson LH; Storwick G; Haber RM
    J Am Acad Dermatol; 2014 Aug; 71(2):398-400. PubMed ID: 25037793
    [No Abstract]   [Full Text] [Related]  

  • 18. Porokeratosis of Mibelli associated with active chronic hepatitis and vitiligo.
    Dippel E; Haas N; Czarnetzki BM
    Acta Derm Venereol; 1994 Nov; 74(6):463-4. PubMed ID: 7701882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C and methotrexate.
    Kujawska A; Clements M; Wise CM; Roberts WN
    Arthritis Rheum; 2003 Dec; 49(6):843-5. PubMed ID: 14673972
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis C virus infection presenting as a polyarthritis: report of 2 cases].
    Cáceres N; Cerda M; Ribalta J; Wainstein E
    Rev Med Chil; 1997 Nov; 125(11):1357-60. PubMed ID: 9609058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.